evaluation of vigabatrin as monotherapy in newly diagnosed partial seizures in childhood.
dc.contributor.author | Perniola, T. | |
dc.contributor.author | Spina, A. | |
dc.contributor.author | Margari, L. | |
dc.contributor.author | Losito, R. | |
dc.contributor.author | Marzocco, P.L. | |
dc.contributor.author | Bello, A. | |
dc.contributor.author | Zizzo, L. | |
dc.date.accessioned | 2013-06-28T11:13:29Z | |
dc.date.accessioned | 2017-10-16T11:37:05Z | |
dc.date.available | 2013-06-28T11:13:29Z | |
dc.date.available | 2017-10-16T11:37:05Z | |
dc.date.issued | 1997 | |
dc.description.abstract | Fifty-three childreen with newly diagnosed partial epilepsies received GVG monotherapy (mean 44/mg/kg/day). After a mean follow up time of 16,5 months, 26 childreen (49%) were seazures-free, 18 (33,9%) had a decrease in seizure frequency and 9 childreen (16,9%) had unchanged seizure frequency. Side effects were reported in 22 childreen (41,5%) and included weight gain, increased appetite and restlessness. | en_US |
dc.identifier.citation | Perniola, T., Spina, A., Margari, L., Losito, R., Marzocco, P. L., Bello, A., . . . Zizzo, L. (1997). Open evaluation of vigabatrin as monotherapy in newly diagnosed partial seizures in childhood. [Monoterapia con vigabatrin nell'epilessia parziale di nuova diagnosi in eta evolutiva: Valutazione in aperto dell' efficacia e della tollerabilita] Bollettino - Lega Italiana Contro l'Epilessia, (99), 141-143. | en_US |
dc.identifier.uri | http://197.255.68.203/handle/123456789/4278 | |
dc.language.iso | en | en_US |
dc.title | evaluation of vigabatrin as monotherapy in newly diagnosed partial seizures in childhood. | en_US |
dc.type | Article | en_US |